Mini-COMET

A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa

Avalglucosidase alfa (GZ402666)OngoingActive not recruitingPhase 2Open NCT03019406 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

Mini-COMET · Trial Tracker · ComplyRx